Welcome to our dedicated page for TTM TECHNOLOGIES SEC filings (Ticker: TTMI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TTM Technologies, Inc. filings document operating results, Regulation FD disclosures, proxy governance, and material events for a Nasdaq-listed manufacturer of mission systems, RF components, RF microwave and microelectronic assemblies, and advanced interconnect products such as PCBs and substrates. The company's 8-K reports furnish quarterly and annual results, outlook commentary, investor-conference disclosures, and registered common-stock information.
Proxy and material-event filings cover annual meeting votes, director elections and retirements, board committee assignments, executive compensation disclosures, shareholder voting matters, and related governance structure, including committee oversight for compensation, audit, nominating and corporate governance, and government security matters.
TTM Technologies SVP Dale Martin Knecht reported selling 2,014 shares of common stock on June 25, 2026 in a series of open-market transactions. Prices ranged roughly from about $205 to $218 per share. According to the filing, the sales were made under a Rule 10b5-1 trading plan adopted on February 24, 2026, solely to pay taxes triggered by the vesting of restricted stock units (RSUs). After these sales, Knecht directly holds 66,336 shares of TTM Technologies common stock.
TTM Technologies EVP and CHRO Shawn A. Powers reported selling 3,367 shares of common stock in open-market transactions. The sales occurred on June 25, 2026 at prices generally around the low-$200s per share, with weighted-average prices disclosed for multiple price ranges from about $204.58 to $218.93.
According to the footnotes, these sales were made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026 and were executed solely to pay the tax liability related to the vesting of restricted stock units (RSUs). After these transactions, Powers continues to hold a significant direct equity position in TTM Technologies.
TTM Technologies EVP, CLO & Secretary Daniel J. Weber sold 2,915 shares of common stock on June 25, 2026 in 13 open-market trades, at weighted-average prices ranging from $204.58 to $218.93. The sales were made under a Rule 10b5-1 plan solely to pay taxes from RSU vesting, and he now directly holds 88,250 shares.
TTM Technologies EVP Douglas L. Soder reported selling a total of 2,874 shares of common stock of TTM Technologies Inc. in multiple open-market transactions on June 25, 2026. The filing states these sales were made under a Rule 10b5-1 trading plan adopted on February 24, 2026 and were executed solely to pay tax liabilities arising from the vesting of RSUs.
After these transactions, Soder directly holds 210,634 shares of TTM Technologies common stock, indicating the sales represent only a small portion of his overall direct holdings. Individual trades ranged from 9 to 1,090 shares, including a sale of 1,090 shares at $208.40 per share, with other sales executed at nearby prices.
TTM Technologies executive Catherine A. Gridley reported selling 3,056 shares of common stock in open-market transactions. The Form 4 shows 13 sales on June 25, 2026 at prices between $204.58 and $218.93 per share.
According to a footnote, these sales were made pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2026 and were executed solely to pay the tax liability arising from the vesting of RSUs, indicating a tax-related liquidity event rather than a discretionary portfolio shift.
TTM Technologies executive Robert P. Farrell reported small, tax-related share sales. On June 25, 2026, the President C&C sold a total of 1,304 shares of TTM Technologies common stock in 13 open-market transactions.
The sales were made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026, and the footnote states they were executed solely to pay the tax liability from vesting restricted stock units (RSUs). Reported sale prices reflect weighted averages, with individual trades occurring in ranges between $204.58 and $218.43 per share.
Weber Daniel J reported acquisition or exercise transactions in this Form 4 filing.
TTM Technologies reported that EVP, CLO & Secretary Daniel J. Weber received a grant of 5,077 restricted stock units of common stock. These units vest in three equal annual installments starting one year after the June 24 grant date. Following this award, Weber holds 91,165 common shares directly.
TTM Technologies Chief Operating Officer James P. Walsh received a grant of 5,263 shares of common stock in the form of restricted stock units. The award is compensation-related and carries no cash exercise price.
The restricted stock units vest in three equal installments on the first, second, and third anniversaries of the June 24 grant date, with shares delivered on or within 30 days of June 24 each year as they vest. Following this award, Walsh directly holds 35,896 shares of TTM Technologies common stock.
Soder Douglas L reported acquisition or exercise transactions in this Form 4 filing.
TTM Technologies executive Douglas L. Soder received a grant of 5,263 restricted stock units of common stock, provided as compensation at no cash cost per share. These units vest in three equal installments on the first, second, and third anniversaries of the June 24 grant date, increasing his direct holdings to 213,508 shares.
Sandeen Anthony Joseph reported acquisition or exercise transactions in this Form 4 filing.
TTM Technologies reported that Anthony Joseph Sandeen, President of its AMI&I Business Unit, received a grant of 1,813 shares of common stock in the form of restricted stock units at no purchase price. His direct holdings after this award total 43,255 common shares.
The restricted stock units vest in three equal installments on the first, second, and third anniversaries of the June 24 grant date, with shares delivered on or within 30 days of June 24 each year. This is a routine, compensation-related equity award rather than an open-market stock purchase or sale.